Dilip Davda
Dilip Davda is a veteran financial journalist and SEBI-registered Research Analyst with over four decades of experience in the Indian capital markets. Based in Maharashtra, he has been a prominent voice in the industry since 1978, specializing in the primary market with a heavy focus on SME IPOs and NCD reviews.
Calls at a glance
Every review on IPO Guru, all time.
Verdict mix
Best and worst call
Call history
Each verdict next to the gain on listing day and the total gain till today, both from the issue price.
| IPO | Verdict | Total gain |
|---|---|---|
|
Nanta TechSME Listed 31 Dec 2025
|
Avoid | +55.5% |
|
Admach SystemsSME Listed 31 Dec 2025
|
Apply | +98.6% |
|
Bai Kakaji PolymersSME Listed 31 Dec 2025
|
Apply | +42.5% |
|
Apollo Techno IndustriesSME Listed 31 Dec 2025
|
May Apply | -37.7% |
|
Gujarat Kidney & Super Speciality Listed 30 Dec 2025
|
Not rated | +39.5% |
|
KSH International Listed 23 Dec 2025
|
Not rated | +166.5% |
|
ICICI Prudential AMC Listed 19 Dec 2025
|
Apply | +39.7% |
|
Nephrocare Health Services Listed 17 Dec 2025
|
Not rated | +39.6% |
|
Park Medi World Listed 17 Dec 2025
|
Not rated | +51.3% |
|
Corona Remedies Listed 15 Dec 2025
|
Not rated | +115.5% |
|
Wakefit Innovations Listed 12 Dec 2025
|
Not rated | -30.8% |
|
Meesho Listed 10 Dec 2025
|
Not rated | +126.3% |
|
Vidya Wires Listed 10 Dec 2025
|
Apply | +48.2% |
|
Aequs Listed 9 Dec 2025
|
Not rated | +91.6% |
|
Sudeep Pharma Listed 28 Nov 2025
|
Apply | +97.1% |
|
Excelsoft Technologies Listed 26 Nov 2025
|
May Apply | -38.6% |
|
Capillary Technologies Listed 21 Nov 2025
|
May Apply | -12.5% |
|
Fujiyama Power Systems Listed 20 Nov 2025
|
Apply | +50.5% |
|
Tenneco Clean Air India Listed 19 Nov 2025
|
Apply | +9.0% |
|
Emmvee Photovoltaic Power Listed 18 Nov 2025
|
Apply | +26.7% |
Frequently asked questions
Is Dilip Davda SEBI registered?
How many IPO reviews has Dilip Davda given?
What is Dilip Davda's IPO recommendation win rate?
What is Dilip Davda's performance score on IPO Guru?
Where can I read Dilip Davda's IPO recommendations?
Compare Dilip Davda with every other analyst.
See who has called IPOs best over the last 18 months.